Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Regulação e direito · 20/12/20241 min de leitura
Hazardous Drugs: NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 and Final Reevaluation Determinations for Liraglutide and Pertuzumab
Tradução automática local · Idioma original da fonte
Resumo
The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services (HHS), announces the publication of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2024, as well as final reevaluation determinations removing the drugs liraglutide and pertuzumab from the NIOSH List of Hazardous Drugs in Healthcare Settings.
Idioma original da fonte: Federal Register — All DocumentsAbrir o comunicado original →